Cardiex Ltd

AU:CDX Australia Medical Devices
Market Cap
$11.58 Million
AU$18.70 Million AUD
Market Cap Rank
#31857 Global
#1016 in Australia
Share Price
AU$0.03
Change (1 day)
-5.56%
52-Week Range
AU$0.03 - AU$0.10
All Time High
AU$2.74
About

Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more

Cardiex Ltd - Asset Resilience Ratio

Latest as of December 2024: 0.16%

Cardiex Ltd (CDX) has an Asset Resilience Ratio of 0.16% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$27.98K
Cash + Short-term Investments
Total Assets
AU$16.99 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Cardiex Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Cardiex Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$27.98K 0.16%
Total Liquid Assets AU$27.98K 0.16%

Asset Resilience Insights

  • Limited Liquidity: Cardiex Ltd maintains only 0.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Cardiex Ltd Industry Peers by Asset Resilience Ratio

Compare Cardiex Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Cardiex Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Cardiex Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 38.50% AU$4.87 Million AU$12.65 Million -0.36pp
2023-06-30 38.86% AU$5.56 Million AU$14.30 Million +30.43pp
2022-06-30 8.43% AU$1.04 Million AU$12.38 Million -5.20pp
2021-06-30 13.63% AU$1.54 Million AU$11.26 Million +6.81pp
2020-06-30 6.82% AU$728.54K AU$10.68 Million +46.59pp
2019-06-30 -39.77% AU$-5.25 Million AU$13.21 Million --
2017-06-30 0.00% AU$0.00 AU$2.96 Million --
2016-06-30 0.00% AU$0.00 AU$4.60 Million --
2003-06-30 0.97% AU$15.00K AU$1.54 Million +0.01pp
2002-06-30 0.96% AU$15.00K AU$1.56 Million --
pp = percentage points